Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Get Free Report) rose 2.5% during mid-day trading on Monday . The company traded as high as $10.60 and last traded at $10.56. Approximately 3,879,922 shares were traded during trading, a decline of 75% from the average daily volume of 15,429,704 shares. The stock had previously closed at $10.30.
Analyst Ratings Changes
WBA has been the subject of a number of recent analyst reports. Barclays dropped their price objective on Walgreens Boots Alliance from $11.00 to $7.00 and set an "underweight" rating for the company in a report on Tuesday, July 23rd. Evercore ISI cut their price target on shares of Walgreens Boots Alliance from $17.00 to $10.00 and set an "in-line" rating on the stock in a report on Friday, June 28th. Royal Bank of Canada reduced their price target on shares of Walgreens Boots Alliance from $22.00 to $13.00 and set a "sector perform" rating on the stock in a research note on Tuesday, July 2nd. Morgan Stanley lowered their price objective on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set an "underweight" rating for the company in a research report on Friday, June 28th. Finally, Truist Financial reduced their target price on shares of Walgreens Boots Alliance from $20.00 to $13.00 and set a "hold" rating on the stock in a research report on Friday, June 28th. Four equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $15.85.
Read Our Latest Research Report on Walgreens Boots Alliance
Walgreens Boots Alliance Price Performance
The firm has a 50-day simple moving average of $11.83 and a 200-day simple moving average of $16.37. The firm has a market cap of $8.96 billion, a P/E ratio of -1.54, a PEG ratio of 0.70 and a beta of 0.72. The company has a current ratio of 0.65, a quick ratio of 0.31 and a debt-to-equity ratio of 0.49.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its quarterly earnings data on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing analysts' consensus estimates of $0.68 by ($0.05). The company had revenue of $36.40 billion for the quarter, compared to the consensus estimate of $35.94 billion. Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. Walgreens Boots Alliance's revenue for the quarter was up 2.8% compared to the same quarter last year. During the same period in the previous year, the business earned $1.00 EPS. As a group, analysts forecast that Walgreens Boots Alliance, Inc. will post 2.87 EPS for the current year.
Walgreens Boots Alliance Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Thursday, September 12th. Investors of record on Wednesday, August 21st will be given a dividend of $0.25 per share. The ex-dividend date is Wednesday, August 21st. This represents a $1.00 dividend on an annualized basis and a yield of 9.63%. Walgreens Boots Alliance's payout ratio is -14.84%.
Institutional Trading of Walgreens Boots Alliance
Institutional investors have recently made changes to their positions in the business. Iron Horse Wealth Management LLC increased its holdings in shares of Walgreens Boots Alliance by 162.5% in the second quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator's stock valued at $25,000 after purchasing an additional 1,300 shares during the period. Pineridge Advisors LLC purchased a new position in shares of Walgreens Boots Alliance during the 4th quarter valued at approximately $26,000. Blue Trust Inc. lifted its stake in shares of Walgreens Boots Alliance by 87.0% in the 2nd quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator's stock valued at $28,000 after purchasing an additional 1,081 shares during the period. Quest Partners LLC purchased a new stake in Walgreens Boots Alliance during the fourth quarter worth $30,000. Finally, Continuum Advisory LLC grew its position in Walgreens Boots Alliance by 71.2% during the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator's stock valued at $30,000 after buying an additional 1,020 shares during the period. Institutional investors and hedge funds own 58.59% of the company's stock.
Walgreens Boots Alliance Company Profile
(Get Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
See Also
- Five stocks we like better than Walgreens Boots Alliance
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Why the Buy-and-Hold Strategy May Be Best for Most Investors
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Eli Lilly’s Path to the Next Trillion Market Capitalization
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Mobileye Global: CEO Makes $10 Million Bet on Future Strength
→ Obama’s final twist in Appalachia (From Porter & Company) (Ad)
Should you invest $1,000 in Walgreens Boots Alliance right now?
Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The Next 7 Blockbuster Stocks for Growth Investors
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report